Dr. Robert Anthony Badalament, MD

Dr. Badalament practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Badalament's NPI, 1003829201, was assigned on August 15, 2006. Dr. Badalament graduated from Emory School of Medicine in 1980. Dr. Badalament holds Florida license ME122147.

Dr. Badalament's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Badalament's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Dr. Badalament is also affiliated with AdventHealth Waterman. The medical group on file is AdventHealth Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Badalament practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Badalament's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Badalament is board certified in urology by the American Board of Urology. Dmand AI has Dr. Badalament's licenses on file in 3 states: Florida, Michigan and Ohio.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Badalament treats.

CMS data shows 930 Medicare services from Dr. Badalament across 14 procedure codes in 2024, for 232 Medicare patients. Medicare paid $44,632 for them.

CMS counts 232 Medicare patients who saw Dr. Badalament in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Badalament's median patient age at 66, with 24% women.

In 2024, Dr. Badalament wrote 760 Medicare Part D claims for 271 patients. 98% of them were for generic drugs. CMS names the drug for 648 of them, across 9 drugs with 11 or more claims each, at $7,293 in total drug cost. In 2023, CMS named 662 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Badalament for performance year 2024, reported as part of a group. Dr. Badalament accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of prostate resection by Dr. Badalament, more than 67% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 83 papers to Dr. Badalament. The most frequent topics are Urinary Bladder Neoplasms, Prostatic Neoplasms and Prostate-Specific Antigen. Dr. Badalament has published most often in J Urol. Dr. Badalament's most frequent co-authors are Duke K. Bahn, MD, Harry W. Herr, MD and John K. Burgers, MD.

CMS Open Payments shows 60 general payments to Dr. Badalament from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. PROCEPT BioRobotics Corporation paid the most, $482.

Dmand AI lists 4 awards for Dr. Badalament.

Dr. Badalament graduated from Emory School of Medicine in 1980. Dr. Badalament is a member of ACS.

Dr. Badalament is in network with 17 carriers, including Aetna, Health Alliance Plan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.